Plain-English translation of NCT07387263 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital tool called GA-Mainstream that helps cancer patients learn about genetic testing and understand their results. Your oncologist may offer you genetic testing to see if you have inherited gene changes that could affect your cancer treatment or care. This study compares patients who use the digital tool with those who receive standard genetic counseling information (like pamphlets or videos) to see which approach helps patients feel less anxious and more informed.
Many cancer centers are shifting genetic testing from genetic counselors to oncologists to handle the growing demand for testing. However, there's no standard way to do this, and patients sometimes feel confused or stressed. This medication is designed to provide patients with clear, personalized education and support in a consistent way, no matter which cancer center they visit.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either use the new digital tool or receive standard genetic counseling materials from your cancer center. Either way, you'll still meet with your oncologist or genetic counselor to discuss your genetic test results. The digital tool guides you through your medical and family history before testing and helps you understand your results afterward. The study will track how you feel about the testing process and whether you understand the information, and it will compare experiences between the two groups.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Canada